Report Code : CVMI0208 | Published Date : Aug. 2, 2025
Market Overview
Transdermal skin patches deliver active pharmaceutical ingredients (APIs) across the skin barrier into systemic circulation, offering a non-invasive, controlled release route that boosts patient compliance. These patches are used in various therapeutic fields including pain management, hormonal therapies, smoking cessation, cardiovascular care, and neurological disorders. Increasing demand for sustained-release drug delivery, elderly-friendly dosage forms, and advances in micro-needle and iontophoretic technologies are driving market growth.
Market Size and Forecast
Year |
Market Value (USD Billion) |
Notes |
2019 |
5.34 |
Includes branded patches and generic equivalents |
2024 |
7.41 |
Five-year CAGR 6.7 % |
2031 |
12.93 |
Seven-year CAGR 8.4 % (2024–2031) |
With growing interest in pain-free drug delivery and extended-release formulations, the transdermal patch market is poised to exceed USD 13 billion by 2031.
Primary Market Drivers
• Preference for non-invasive, sustained drug delivery
• Aging populations and polypharmacy challenges
• High compliance in chronic therapies such as Alzheimer’s, hypertension, and contraception
• Rising adoption of wearable therapeutics in homecare
• Demand for precision dosing in pediatric and geriatric populations
Market Challenges
• Limited molecule suitability due to skin permeability barriers
• Risk of skin irritation, adhesive allergy, and dose dumping
• Competition from oral extended-release formulations
• Regulatory complexities in bioequivalence and patch performance
• High development cost for newer actives requiring penetration enhancers
Competitive Landscape
Company / Organization |
2024 Share |
Core Strengths |
Recent Moves |
Hisamitsu Pharmaceutical |
16 % |
Global leader in pain relief patches |
Expanded salonpas Rx distribution in US retail (Q2 2024) |
Novartis (Sandoz) |
13 % |
Nicotine and hormone patch generics |
Filed ANDA for Rivastigmine patch (Q1 2025) |
Teva Pharmaceuticals |
11 % |
Broad transdermal generics and CNS pipeline |
Launched clonidine ER patch for ADHD (Q3 2024) |
Luye Pharma |
9 % |
CNS and oncology-focused transdermal R&D |
Initiated Phase 3 trials for rotigotine patch (Q4 2024) |
Others (Mylan, Nitto, Tapemark) |
51 % |
Regional partnerships and CDMO offerings |
Scaling iontophoretic patch platforms for APIs |
Detailed Market Segmentation
By Application
• Pain Management – 34 %
• Hormonal Therapy – XX %
• Smoking Cessation – XX %
• Cardiovascular Disease – XX %
• Neurological Disorders – XX %
By Patch Type
• Matrix Type – 47 %
• Reservoir Type – XX %
• Drug-in-Adhesive – XX %
• Vapor Patch – XX %
• Micro-Needle & Iontophoretic – XX %
By Distribution Channel
• Hospital Pharmacies – XX %
• Retail Pharmacies – 41 %
• Online Pharmacies – XX %
• Institutional Supply – XX %
Regional Analysis
• North America (42%) – Largest market; broad payer coverage and OTC access for nicotine and analgesic patches
• Europe (XX%) – High use in menopausal hormone therapy and neurological disease management
• Asia-Pacific (XX%) – Growing elderly population, increasing OTC analgesic use
• Latin America & MEA (8%) – Expansion via regional distribution of low-cost patches for chronic care
Technology and Innovation
• Microneedle-enhanced patches enabling macromolecule delivery
• Smart patches with sensor-based adherence tracking
• Temperature-sensitive and time-triggered delivery systems
• Iontophoresis-based patches for rapid-onset APIs
• Improvements in bioadhesive and breathable polymer matrices
Regulatory Environment
• US FDA requires in vitro skin permeation and clinical BE studies for generics
• EMA guidelines cover adhesive performance and residual drug content validation
• Japan PMDA supports innovation in polymer systems and temperature-sensitive materials
• Global trend toward harmonized patch testing protocols
Recent Developments (Q4 2023 – Q2 2025)
• Hisamitsu expanded its Rx line in the US and Brazil with new diclofenac patches (Q2 2024)
• Luye Pharma initiated a late-stage rotigotine transdermal trial (Q4 2024)
• Tapemark and Nitto announced a co-development deal for a wearable patch (Q3 2024)
• Sandoz filed an application for a generic Alzheimer's patch in the US (Q1 2025)
• Iontophoretic patch for insulin delivery completed feasibility studies (Q1 2025)
Strategic Outlook
• Companies should pursue molecule-patch pairing strategies focused on chronic and CNS conditions
• Wearable tech convergence and adherence tracking can differentiate new platforms
• Expansion into OTC and telehealth channels enhances reach in aging markets
• Contract development partnerships for polymer systems and iontophoresis platforms offer growth
Methodology
Clearview Market Insights aggregated patch sales data, reviewed ANDA pipelines, and conducted 56 interviews with transdermal drug delivery researchers and formulation specialists. Demand modeling included chronic therapy prevalence, patch penetration rates, and payer formulary coverage.
About Clearview Market Insights
Clearview Market Insights delivers targeted research in advanced drug delivery, chronic therapy compliance, and digital therapeutics. Our analyst team supports CDMOs, pharmaceutical OEMs, and health tech investors with actionable foresight.
Reasons To Buy
• Benchmark the competitive landscape in pain, hormone, and neurotherapeutic patches
• Understand payer and formulary trends in transdermal delivery
• Identify opportunities in smart wearable therapeutic patches
• Monitor CDMO and polymer tech partner developments
Scope
• Global and regional revenue trends through 2031 by application and patch type
• Profiles of top patch developers and pipeline innovations
• Regulatory and payer trends in extended-release drug formats
• Innovation outlook for microneedle, smart patch, and biosensor-enabled delivery
- Hisamitsu Pharmaceutical
- Teva Pharmaceuticals
- Luye Pharma
- Mylan,
- Nitto
- Tapemark
- Teikoku Pharma USA Inc.
- Viatris Inc.
- Johnson & Johnson
- Purdue Pharma Manufacturing LP
Global Transdermal Skin Patches Market Report
- 1. Global Transdermal Skin Patches Market Research Report
- 1.1 Study Objectives
- 1.2 Global Transdermal Skin Patches Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Global Transdermal Skin Patches Market Research Report - Preface
- 2.1 Global Transdermal Skin Patches Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Application
- 2.1.2 By Patch Type
- 2.1.3 By Distribution Channel
- 2.1.4 By Region
- 2.1 Global Transdermal Skin Patches Market Research Report – Detailed Scope and Definitions
- 3. Global Transdermal Skin Patches Market Dynamics
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Application, By Patch Type, By Distribution Channel, By Country
- 3.3. Opportunities – By Application, By Patch Type, By Distribution Channel, By Country
- 3.4. Trends – By Application, By Patch Type, By Distribution Channel, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Transdermal Skin Patches Market Research Report – DROTs Impact Analysis
-
- 4. Global Transdermal Skin Patches Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5. Global Transdermal Skin Patches Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1 Pain Management
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Hormonal Therapy
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Smoking Cessation
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.4 Cardiovascular Disease
- 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.5 Neurological Disorders
- 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Matrix Type
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Reservoir Type
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Drug-in-Adhesive
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Vapor Patch
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.5 Micro-Needle & Iontophoretic
- 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospital Pharmacies
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Retail Pharmacies
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Online Pharmacies
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Institutional Supply
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8. Global Transdermal Skin Patches Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 9. North America Global Transdermal Skin Patches Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 9.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Pain Management
- 9.1.2 Hormonal Therapy
- 9.1.3 Smoking Cessation
- 9.1.4 Cardiovascular Disease
- 9.1.5 Neurological Disorders
- 9.2.1 Matrix Type
- 9.2.2 Reservoir Type
- 9.2.3 Drug-in-Adhesive
- 9.2.4 Vapor Patch
- 9.2.5 Micro-Needle & Iontophoretic
- 9.3.1 Hospital Pharmacies
- 9.3.2 Retail Pharmacies
- 9.3.3 Online Pharmacies
- 9.3.4 Institutional Supply
- 9.4.1 U.S
- 9.4.2 Canada
- 9.5 North America Global Transdermal Skin Patches Market – Opportunity Analysis Index, By Application, By Patch Type, By Distribution Channel, and Country, 2024 - 2031
- 9.6 Regional Trends Analysis
- 9.7 North America Global Transdermal Skin Patches Market Research Report - Company Profiles
- 9.7.1 Company 1 (U.S)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Pain Management
- 10.1.2 Hormonal Therapy
- 10.1.3 Smoking Cessation
- 10.1.4 Cardiovascular Disease
- 10.1.5 Neurological Disorders
- 10.2.1 Matrix Type
- 10.2.2 Reservoir Type
- 10.2.3 Drug-in-Adhesive
- 10.2.4 Vapor Patch
- 10.2.5 Micro-Needle & Iontophoretic
- 10.3.1 Hospital Pharmacies
- 10.3.2 Retail Pharmacies
- 10.3.3 Online Pharmacies
- 10.3.4 Institutional Supply
- 10.4.1 Germany
- 10.4.2 UK
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Poland and Rest of Europe
- 10.5 Europe Global Transdermal Skin Patches Market – Opportunity Analysis Index, By Application, By Patch Type, By Distribution Channel, and Country, 2024 - 2031
- 10.6 Regional Trends Analysis
- 10.7 Europe Global Transdermal Skin Patches Market Research Report - Company Profiles
- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (UK)
- 10.7.3 Company 3 (UK)
- 11.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Pain Management
- 11.1.2 Hormonal Therapy
- 11.1.3 Smoking Cessation
- 11.1.4 Cardiovascular Disease
- 11.1.5 Neurological Disorders
- 11.2.1 Matrix Type
- 11.2.2 Reservoir Type
- 11.2.3 Drug-in-Adhesive
- 11.2.4 Vapor Patch
- 11.2.5 Micro-Needle & Iontophoretic
- 11.3.1 Hospital Pharmacies
- 11.3.2 Retail Pharmacies
- 11.3.3 Online Pharmacies
- 11.3.4 Institutional Supply
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 ASEAN
- 11.4.5 Australia & New Zealand
- 11.4.6 Rest of Asia-Pacific
- 11.5 Asia-Pacific Global Transdermal Skin Patches Market – Opportunity Analysis Index, By Application, By Patch Type, By Distribution Channel, and Country, 2024 - 2031
- 11.6 Regional Trends Analysis
- 11.7 Asia-Pacific Global Transdermal Skin Patches Market Research Report - Company Profiles
- 11.7.1 Company 1 (Japan)
- 11.7.2 Company 2 (China)
- 11.7.3 Company 3 (China)
- 12.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Pain Management
- 12.1.2 Hormonal Therapy
- 12.1.3 Smoking Cessation
- 12.1.4 Cardiovascular Disease
- 12.1.5 Neurological Disorders
- 12.2.1 Matrix Type
- 12.2.2 Reservoir Type
- 12.2.3 Drug-in-Adhesive
- 12.2.4 Vapor Patch
- 12.2.5 Micro-Needle & Iontophoretic
- 12.3.1 Hospital Pharmacies
- 12.3.2 Retail Pharmacies
- 12.3.3 Online Pharmacies
- 12.3.4 Institutional Supply
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Rest of Latin America
- 12.5 Latin America Global Transdermal Skin Patches Market – Opportunity Analysis Index, By Application, By Patch Type, By Distribution Channel, and Country, 2024 - 2031
- 12.6 Regional Trends Analysis
- 12.7 Latin America Global Transdermal Skin Patches Market Research Report - Company Profiles
- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Pain Management
- 13.1.2 Hormonal Therapy
- 13.1.3 Smoking Cessation
- 13.1.4 Cardiovascular Disease
- 13.1.5 Neurological Disorders
- 13.2.1 Matrix Type
- 13.2.2 Reservoir Type
- 13.2.3 Drug-in-Adhesive
- 13.2.4 Vapor Patch
- 13.2.5 Micro-Needle & Iontophoretic
- 13.3.1 Hospital Pharmacies
- 13.3.2 Retail Pharmacies
- 13.3.3 Online Pharmacies
- 13.3.4 Institutional Supply
- 13.4.1 Gulf Cooperation Council (GCC) Countries
- 13.4.2 Israel
- 13.4.3 South Africa
- 13.4.4 Rest of MEA
- 13.5 Middle East and Africa Global Transdermal Skin Patches Market – Opportunity Analysis Index, By Application, By Patch Type, By Distribution Channel, and Country, 2024 - 2031
- 13.6 Regional Trends Analysis
- 13.7 Middle East and Africa Global Transdermal Skin Patches Market Research Report - Company Profiles
- 13.7.1 Company 1 (Gulf Cooperation Council (GCC) Countries)
- 13.7.2 Company 2 (Israel)
- 13.7.3 Company 3 (Israel)
- 14.1 Strategic Dashboard of Top Market Players
- 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 14.2.1 Hisamitsu Pharmaceutical
- 14.2.2 Hisamitsu Pharmaceutical
- 14.2.3 Teva Pharmaceuticals
- 14.2.4 Luye Pharma
- 14.2.5 Mylan
- 14.2.6 Nitto
- 14.2.7 Tapemark
- 14.2.8 Teikoku Pharma USA Inc.
- 14.2.9 Viatris Inc.
- 14.2.10 Johnson & Johnson
- 14.2.11 Purdue Pharma Manufacturing LP
- 9.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 15. Data Collection Method and Research Approach
- 16. Principal Presumptions and Acronyms